Rehabilitative interventions in patients with persistent post COVID-19 symptoms—a review of recent advances and future perspectives 2023, Gloeckl etal

Abstract


The SARS-CoV-2 pandemic has not only caused millions of deaths but left also millions of people with persistent symptoms behind. These long-term COVID-19 sequelae cause a considerable burden on individuals´ health, healthcare systems, and economies worldwide given the high rate of SARS-CoV-2 infections. Therefore, rehabilitative interventions and strategies are needed to counteract the post COVID-19 sequelae.

The importance of rehabilitation for patients with persistent COVID-19 symptoms has been recently also highlighted in a Call for Action by the World Health Organisation. Based on previously published research, but also in line with clinical experience, COVID-19 is not one specific disease but rather presents in different phenotypes that vary in their pathophysiological mechanisms, symptomatic manifestations, and potential interventional approaches.

This review provides a proposal for differentiating post COVID-19 patients in non-organ-specific phenotypes that may help clinicians to evaluate patients and to plan therapeutic options. Furthermore, we present current unmet needs and suggest a potential pathway for a specific rehabilitation approach in people with persistent post-COVID symptoms.

https://link.springer.com/article/10.1007/s00406-023-01631-9

 

Some might think of finding out what has actually gone wrong within human biology before rushing to create money spinning/saving ideas at the expense of peoples long term health .It seems the entire medical industry has forgotten that science is a necessary part of finding real long term solutions to health problems.

 

The ME/CFS subtype of LC shouldn't be considered rare. We know, among those ill enough to visit a long Covid clinic, around 40% would meet the diagnostic criteria for ME/CFS.

 

A few papers have come out with numbers around 40-50%. For example, see our thread on: [Preprint] Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC), 2022, Bonilla+